Stem cell transplantation for ischemic myocardium

Italian Heart Journal

Volumn 5, Issue 5, 2004, Pages 340-342

  Mariani, Massimo A ^a   D'Alfonso, Alessandro ^a   Croccia, Mariagrazia ^a   Limbruno, Ugo ^a   Di Stefano, Rosella ^a   Grandjean, Jan G ^a  

^a UNIVERSITY HOSPITAL OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOLOGY; EDITORIAL; HEART MUSCLE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HUMAN; PATHOLOGY; STEM CELL TRANSPLANTATION; TRANSPLANTATION;

HUMANS; MYOCARDIAL ISCHEMIA; MYOCARDIUM; MYOCYTES, CARDIAC; STEM CELL TRANSPLANTATION;

EID: 7044286100     PISSN: 1129471X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Ryan EA, Lakey JR, Rajotte RV, et al. Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. Diabetes 2001; 50: 710-9.
2. Kajstura J, Leri A, Finato N, Di Loreto C, Beltrami CA. Myocyte proliferation in end-stage cardiac failure in humans. Proc Natl Acad Sci USA 1998; 95: 8801-5.
3. Beltrami AP, Urbanek K, Kajstura J, et al. Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med 2001; 344: 1750-7.
4. Yoo KJ, Li RK, Weisel RD, et al. Heart cell transplantation improves heart function in dilated cardiomyopathic hamsters. Circulation 2000; 102 (Suppl 3): 204-9.
5. Scorsin M, Hagege AA, Dolizy I, et al. Can cellular transplantation improve function in doxorubicin-induced heart failure? Circulation 1998; 98 (Suppl 2): 151-6.
6. Hutcheson KA, Atkins BZ, Hueman MT, Hopkins MB, Glower DD, Taylor DA. Comparison of benefits on myocardial performance of cellular cardiomyoplasty with skeletal myoblasts and fibroblasts. Cell Transplant 2000; 9: 359-68.
7. Sakai T, Li RK, Weisel RD, et al. Fetal cell transplantation: a comparison of three cell types. J Thorac Cardiovasc Surg 1999; 118: 715-25.
8. Kim EJ, Li RK, Weisel RD, et al. Angiogenesis by endothelial cell transplantation. J Thorac Cardiovasc Surg 2001; 122: 963-71.
9. Nir SG, David R, Zaruba M, Franz WM, Itskovitz-Eldor J. Human embryonic stem cells for cardiovascular repair. Cardiovasc Res 2003; 58: 313-23.
10. Menasche P, Vilquin JT, Desnos M, et al. Early results of autologous skeletal myoblast transplantation in patients with severe ischemic heart failure. (abstr) Circulation 2001; 104: II-598.
11. Bigger JT, Whang W, Rottman JN, et al. Mechanism of death in the CABG Patch trial: a randomized trial of implantable cardiac defibrillator prophylaxis in patients at high risk of death after coronary artery bypass graft surgery. Circulation 1999; 99: 1416-21.
12. Stamm C, Westphal B, Kleine HD, et al. Autologous bonemarrow stem cell transplantation for myocardial regeneration. Lancet 2003; 361: 45-6.
13. Tse HF, Lau CP, Kwong YL. Therapeutic angiogenesis of ischemic myocardium using percutaneous delivery of autologous bone marrow cells. (abstr) J Am Coll Cardiol 2002; 39: 75A.
14. Orlic D, Kajstura J, Chimenti S, et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001; 410: 701-5.
15. Orlic D, Kajstura J, Chimenti S, et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci USA 2001; 98: 10344-9.
16. Tomita S, Li RK, Weisel RD. Autologous transplantation of bone marrow cells improves damaged heart function. Circulation 1999; 100 (Suppl 2): 247-56.
17. Tomita S, Mickle DA, Weisel RD, et al. Improved heart function with myogenesis and angiogenesis after autologous porcine bone marrow stromal cell transplantation. J Thorac Cardiovasc Surg 2002; 123: 1132-40.
18. Toma C, Pittenger MF, Cahill KS, Byrne BJ, Kessler PD. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 2002; 105: 93-8.
19. Duan HF, Wu CT, Wu DL, et al. Treatment of myocardial ischemia with bone marrow-derived mesenchymal stem cells overexpressing hepatocyte growth factor. Mol Ther 2003; 8: 467-74.
20. Rangappa S, Entwistle JW, Wechsler AS, Kresh JY. Cardiomyocyte-mediated contact programs human mesenchymal stem cells to express cardiogenic phenotype. J Thorac Cardiovasc Surg 2003; 126: 124-32.
21. Grossman PM, Han Z, Palasis M, Barry JJ, Lederman RJ. Incomplete retention after direct myocardial injection. Catheter Cardiovasc Interv 2002; 55: 392-7.
22. Zhang M, Methot D, Poppa V, et al. Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies. J Mol Cell Cardiol 2001; 33: 907-21.
23. Mangi AA, Noiseux N, Kong D, et al. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 2003; 9: 1195-201.
24. Zhang M, Methot D, Poppa V, Fujio Y, Walsh K, Murry CE. Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies. J Mol Cell Cardiol 2001; 33: 907-21.
25. Li RK, Mickle DA, Weisel RD, Rao V, Jia ZQ. Optimal time for cardiomyocyte transplantation to maximize myocardial function after left ventricular injury. Ann Thorac Surg 2001; 72: 1957-63.
26. Ferrari G, Cusella-De Angelis G, Coletta M, et al. Muscle regeneration by bone marrow-derived myogenic progenitors. Science 1998; 279: 1528-30.